ContraFect Financial Statements From 2010 to 2025

CFRXDelisted Stock  USD 1.18  0.08  6.35%   
ContraFect Corp financial statements provide useful quarterly and yearly information to potential ContraFect Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on ContraFect Corp financial statements helps investors assess ContraFect Corp's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting ContraFect Corp's valuation are summarized below:
ContraFect Corp does not presently have any fundamental signals for analysis.
Check ContraFect Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ContraFect Corp's main balance sheet or income statement drivers, such as , as well as many indicators such as . ContraFect financial statements analysis is a perfect complement when working with ContraFect Corp Valuation or Volatility modules.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

ContraFect Corp Company Shares Outstanding Analysis

ContraFect Corp's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current ContraFect Corp Shares Outstanding

    
  10.7 M  
Most of ContraFect Corp's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ContraFect Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, ContraFect Corp has 10.7 M of shares currently outstending. This is 94.07% lower than that of the Biotechnology sector and 89.98% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 98.13% higher than that of the company.

ContraFect Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ContraFect Corp's current stock value. Our valuation model uses many indicators to compare ContraFect Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ContraFect Corp competition to find correlations between indicators driving ContraFect Corp's intrinsic value. More Info.
ContraFect Corp is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ContraFect Corp's earnings, one of the primary drivers of an investment's value.

About ContraFect Corp Financial Statements

ContraFect Corp investors use historical fundamental indicators, such as ContraFect Corp's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in ContraFect Corp. Please read more on our technical analysis and fundamental analysis pages.
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York. Contrafect operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 38 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Consideration for investing in ContraFect Stock

If you are still planning to invest in ContraFect Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ContraFect Corp's history and understand the potential risks before investing.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume